We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LZM icon
1476
Lifezone Metals
LZM
$370M
$150K 0.01%
+35,013
New +$158K
VIR icon
1477
Vir Biotechnology
VIR
$1.49B
$150K 0.01%
24,941
+10,195
+69% +$60.7K
GFR icon
1478
Greenfire Resources
GFR
$771M
$149K 0.01%
31,222
-9,922
-24% -$47.1K
SGMT icon
1479
Sagimet Biosciences
SGMT
$559M
$149K 0.01%
25,196
-60,052
-70% -$431K
ZH
1480
Zhihu
ZH
$279M
$147K 0.01%
44,878
-107,421
-71% -$430K
AMTX icon
1481
Aemetis
AMTX
$124M
$146K 0.01%
105,218
-74,572
-41% -$150K
CNTY icon
1482
Century Casinos
CNTY
$34M
$146K 0.01%
109,562
+15,891
+17% +$28.4K
HOFT icon
1483
Hooker Furnishings Corp
HOFT
$166M
$146K 0.01%
12,890
-4,482
-26% -$45.1K
RES icon
1484
RPC Inc
RES
$1.3B
$146K 0.01%
26,761
+5,396
+25% +$28K
USGO icon
1485
US GoldMining
USGO
$120M
$146K 0.01%
+16,522
New +$181K
CSBR icon
1486
Champions Oncology
CSBR
$72.1M
$145K 0.01%
20,978
+10,563
+101% +$70.3K
NXDR
1487
Nextdoor Holdings
NXDR
$986M
$143K 0.01%
68,062
-32,123
-32% -$63K
GWH icon
1488
ESS Tech
GWH
$18.9M
$140K 0.01%
+74,724
New +$238K
CAL icon
1489
Caleres
CAL
$487M
$139K 0.01%
+11,403
New +$140K
GGR icon
1490
Gogoro
GGR
$51.2M
$139K 0.01%
50,678
+11,945
+31% +$48.2K
JSPR icon
1491
Jasper Therapeutics
JSPR
$23.6M
$137K 0.01%
+74,964
New +$150K
XPER icon
1492
Xperi
XPER
$348M
$136K 0.01%
23,271
+4,988
+27% +$31.3K
NVCR icon
1493
NovoCure
NVCR
$1.91B
$135K 0.01%
+10,461
New +$134K
KLTR icon
1494
Kaltura
KLTR
$267M
$134K 0.01%
81,615
-29,917
-27% -$47.3K
PRME icon
1495
Prime Medicine
PRME
$559M
$134K 0.01%
+38,510
New +$171K
OKUR
1496
OnKure Therapeutics
OKUR
$168M
$133K 0.01%
45,948
-13,276
-22% -$39.7K
CAAS icon
1497
China Automotive Systems
CAAS
$133M
$132K 0.01%
30,956
-6,989
-18% -$29.9K
FBIO icon
1498
Fortress Biotech
FBIO
$88.7M
$132K 0.01%
+36,074
New +$103K
RFIL icon
1499
RF Industries
RFIL
$139M
$132K 0.01%
22,892
+5,808
+34% +$40.2K
BHC icon
1500
Bausch Health
BHC
$2.34B
$131K 0.01%
+18,872
New +$124K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.